All regulatory communications have data.
Successful communications have a story.
Work with 3D to get your story straight from the start.
Address issues and questions effectively to mitigate
potential major objections.
Establish open and constructive communications with EMA-CHMP.
Develop a clear, consistent scientific narrative supporting EU approval.
Submit compelling written responses to EMA Day 120 / 180 requests.
That’s where 3D comes in. 3D helps you
-
Proactively identify potential actions and analyses that address questions.
-
Develop responses that address questions and issues while bridging back to key approval messages.
-
Facilitate collaboration with functional experts to enhance written responses that resolve major objections.
We work with you to resolve EMA concerns during MAA review—so you achieve marketing authorization in the EU.
LoOI = List of Outstanding Issues; LoQ = List of Questions
Our Latest Thinking
- How To Break Through The Technology And Help Health Educators Connect And Communicate Virtually With Providers And Patients
- Time to Get Real About Real-World Evidence – More Action, Less Talk Could Accelerate Access to New Medicines, Pharma Industry Experts Say
- Setting Up An Association President To Be A Virtual "Overnight" Sensation
Our proven process 3D ACT® is not magic. It's better.
Learn Why